MedPath

Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling

Not Applicable
Completed
Conditions
Alopecia Areata
Interventions
Device: Tattoo machine (SOL Nova Device)
Registration Number
NCT04338295
Lead Sponsor
Yale University
Brief Summary

The investigators propose to study the efficacy of micro-needling via the SOL Nova Device in generating hair growth in patients with Alopecia Areta (AA) who are either non-responsive or only partially responsive to combination oral JAK inhibitor plus oral minoxidil therapy.

Detailed Description

This will be a trial evaluating the efficacy of micro-needling via tattoo device in stimulating scalp hair growth in patients with AA refractory to combination JAK inhibitor and oral minoxidil treatment. Ten healthy subjects who are at least eighteen years of age who have experienced no or partial scalp hair regrowth after ≥three months of JAK inhibitor plus oral minoxidil treatment will be enrolled. Subjects will undergo a treatment session once every thirty days for a total of six sessions over six months and will complete a total of eight visits over eight months. Procedures and visits are not standard of care but conducted for research. Each visit will last about an hour. Approximately 30 minutes will be spent on consenting and time for patient to ask questions during the first visit. The remaining 30 minutes will be allotted for the investigator to determine if the patient meets criteria for trial enrollment. During the remaining visits, 20 minutes will be allotted for photography, 15-20 minutes for the procedure and 10-15 minutes for post-procedure patient assessment. Remaining 10 minutes on visits 2 and 8 will be used for biopsy.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
5
Inclusion Criteria
  • Diagnosis of AA
  • SALT score ≥90%
  • No or minimal scalp hair regrowth after ≥three months of oral JAK inhibitor plus oral minoxidil treatment
Read More
Exclusion Criteria
  • Known concomitant androgenetic or other form of alopecia (in addition to AA)
  • Patients with the following who would make poor candidates for microneedling such as skin conditions, diabetes, or history of keloid formation
  • Anything additional existing comorbidities that in the opinion of the investigator may cause unnecessary risk for the patient to participate
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MicroneedlingTattoo machine (SOL Nova Device)Participants with Alopecia Areata will receive microneedling with a tattoo machine.
Primary Outcome Measures
NameTimeMethod
Target area hair count (TAHC)6 months

Total number of hairs in the area that undergoes microneedling

Secondary Outcome Measures
NameTimeMethod
Terminal hairs6 months

Number of terminal hairs in an area of 1cm\^2

Vellus hairs6 months

Number of vellus hairs in an area of 1cm\^2

Hair phase6 months

Number of catagen, anagen hairs

Trial Locations

Locations (1)

Yale University

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath